Triocim 50 ml is indicated for the treatment of the following infections when caused by susceptible organisms:
Upper Respiratory Tract Infections (URTI):
Including otitis media and other URTIs where the causative organism is resistant to commonly used antibiotics or where treatment failure may carry significant risk
Lower Respiratory Tract Infections:
Such as bronchitis
Urinary Tract Infections (UTI):
Including cystitis, cystourethritis, and pyelonephritis
Typhoid fever (according to recommended dosing)
Clinical efficacy has been demonstrated against common pathogens such as Streptococcus pneumoniae, Streptococcus pyogenes, Escherichia coli, Proteus mirabilis, Klebsiella species, Haemophilus influenzae (beta-lactamase positive and negative), Moraxella catarrhalis, and Enterobacter species.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Third Generation Cephalosporins
Cefixime is a third-generation semisynthetic cephalosporin antibiotic intended for oral administration. It exerts a bactericidal effect by inhibiting bacterial cell wall synthesis. Due to its high stability against beta-lactamase enzymes, Cefixime remains effective against many organisms resistant to penicillins and some cephalosporins. Oral absorption is approximately 40–50% and is not significantly affected by food intake.
Children (6 months or older):
Recommended dose is 8 mg/kg/day, administered as a single dose or in two divided doses
General daily dosing guide:
6 months to 1 year: 75 mg (3.75 ml) daily
1–4 years: 100 mg (5 ml) daily
5–10 years: 200 mg (10 ml) daily
11–12 years: 300 mg daily
Typhoid fever:
5 mg/kg body weight twice daily for 10–14 days
Children weighing over 50 kg or older than 10 years:
200–400 mg daily, similar to adult dosing
Children under 6 months:
Safety and efficacy have not been established
The usual course of treatment is 7 days, which may be extended up to 14 days depending on infection severity.
Normal dosing may be used if creatinine clearance is ≥20 ml/min
If creatinine clearance is <20 ml/min, the dose should not exceed 200 mg once daily
Same recommendation applies to patients on hemodialysis or peritoneal dialysis
As with other cephalosporins, increased prothrombin time has been observed in some patients. Caution is advised when used concurrently with anticoagulant therapy.
Triocim 50 ml is contraindicated in patients with known hypersensitivity to cephalosporin antibiotics.
Triocim 50 ml is generally well tolerated. Most adverse reactions are mild and self-limiting.
Gastrointestinal: Diarrhea, stool changes, nausea, abdominal pain, dyspepsia, vomiting, flatulence; rare cases of pseudomembranous colitis
Central Nervous System: Headache, dizziness
Hypersensitivity: Rash, pruritus, urticaria, drug fever, arthralgia
Hematological: Thrombocytopenia, leukopenia, eosinophilia (rare and reversible)
Others: Transient changes in liver and renal function tests, genital pruritus, vaginitis
There are no adequate and well-controlled studies in pregnant women. Triocim 50 ml should be used during pregnancy only if clearly needed. It is not known whether Cefixime is excreted in human milk; therefore, caution should be exercised when administered to nursing mothers.
Use cautiously in patients with a history of penicillin hypersensitivity due to possible cross-reactivity
Discontinue immediately if allergic reactions occur
Administer with caution in patients with severe renal impairment
Prolonged use may result in overgrowth of non-susceptible organisms, including Clostridium difficile
No specific antidote is available. Gastric lavage may be considered if appropriate. Cefixime is not significantly removed by hemodialysis or peritoneal dialysis.
Store below 30°C, protected from light and moisture. Keep out of the reach of children.
Login Or Registerto submit your questions to seller
No none asked to seller yet